BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasonov EL, Korotaeva TV. Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology. Naučno-praktičeskaâ revmatologiâ 2022;60:131-148. [DOI: 10.47360/1995-4484-2022-131-148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasonov EL, Feist E. The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Naučno-praktičeskaâ revmatologiâ 2022;60:505-518. [DOI: 10.47360/1995-4484-2022-505-518] [Reference Citation Analysis]
2 Vorobyeva LD, Korotaeva TV, Loginova EY, Korsakova YL, Gubar EE, Nasonov EL. Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice. Naučno-praktičeskaâ revmatologiâ 2022;60:334-340. [DOI: 10.47360/1995-4484-2022-334-340] [Reference Citation Analysis]